Core Viewpoint - Boya Bio announced a semi-annual distribution plan for 2025, proposing a cash dividend of 1.5 yuan per 10 shares, totaling approximately 75.64 million yuan, which represents 33.57% of the company's net profit [2]. Company Financials - For the first half of 2025, Boya Bio reported revenue of 1.008 billion yuan, a year-on-year increase of 12.51%. However, net profit decreased by 28.68% to 225 million yuan, with basic earnings per share at 0.45 yuan and a weighted average return on equity of 2.97% [2]. Dividend History - The company has distributed dividends 16 times since its listing. The latest distribution plan is as follows: - 2025.06.30: 10 shares, 1.5 yuan (total 0.76 billion yuan, dividend yield 0.54%) - 2024.12.31: 10 shares, 1.6 yuan (total 0.81 billion yuan, dividend yield 0.51%) - 2024.06.30: 10 shares, 1.6 yuan (total 0.81 billion yuan, dividend yield 0.53%) - 2023.12.31: 10 shares, 3 yuan (total 1.51 billion yuan, dividend yield 0.87%) [2]. Industry Comparison - In the pharmaceutical and biotechnology sector, 24 companies announced their semi-annual distribution plans for 2025. Boya Bio's cash distribution of 75.64 million yuan ranks it among the lower end of the spectrum compared to peers like WuXi AppTec, which announced a distribution of 1.003 billion yuan [4].
博雅生物公布2025半年度分配预案 拟10派1.5元